🔮 OOTWOracle · All predictions · Odds sheet · Track record · Benchmark

DEA does not reschedule psilocybin this year even if FDA approves; scheduling review lags approval substantially.

Predicted 2026-06-18 · Resolves 2026-12-31 · regulation · USA
78%
ORACLE CONFIDENCE
⏳ Pending
Every outcome is scored publicly in the ledger.

Here's something surprising: even if the FDA (the US drug regulator) officially approves psilocybin as a medicine, that doesn't automatically make it legal to prescribe or use. The DEA (the federal drug enforcement agency) runs a completely separate review process to decide what 'schedule' — meaning legal category — a drug belongs to, and that process is slow and cautious. So there could be a gap where psilocybin is technically FDA-approved but still federally illegal to distribute.

Scheduling is a separate, evidence-heavy administrative process. Law enforcement caution outweighs clinical momentum in my division's calculus.

5 new falsifiable predictions, every day at 12:05 PM ET.
Get tomorrow's Oracle →